nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
2024 at Clinical Therapeutics: Looking Back . . . Looking Ahead
|
Beninger, Paul |
|
|
46 |
1 |
p. 1-2 |
artikel |
2 |
Clinical Bridging From Prefilled Syringe to On-body Injector for Risankizumab in Crohn's Disease
|
Pang, Yinuo |
|
|
46 |
1 |
p. 30-39 |
artikel |
3 |
Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care
|
Al-Taie, Anmar |
|
|
46 |
1 |
p. e29-e44 |
artikel |
4 |
Combination Therapy Use and Associated Events in Clinical Practice Following Dissemination of Trial Findings: A De-Implementation Study Using Interrupted Time Series Analysis
|
Campbell, Heather M. |
|
|
46 |
1 |
p. 40-49 |
artikel |
5 |
Editorial Board
|
|
|
|
46 |
1 |
p. i-ii |
artikel |
6 |
Effectiveness of High-dose Clonazepam Versus Low-Dose Clonazepam With Cognitive Behavioral Therapy in Older Adults With Moderately Severe Insomnia: A Prospective Cohort Study
|
Sankar, Karthik |
|
|
46 |
1 |
p. 69-73 |
artikel |
7 |
Estimating Changes in Weight and Metabolic Parameters Before and After Treatment With Cariprazine: A Retrospective Study of Electronic Health Records
|
Masand, Prakash S. |
|
|
46 |
1 |
p. 50-58 |
artikel |
8 |
Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis
|
Ito, Diane |
|
|
46 |
1 |
p. 3-11 |
artikel |
9 |
Ledipasvir/Sofosbuvir in Hepatitis C Virus–Infected Children With Hematological Malignancies: A Pharmacokinetic Study
|
AbdelMagid, Aya M. |
|
|
46 |
1 |
p. e12-e22 |
artikel |
10 |
Muscle Strength Decline Caused by Eperisone Hydrochloride: A Case Report
|
Zhu, Junteng |
|
|
46 |
1 |
p. 74-78 |
artikel |
11 |
Partnering for Better Health: Using Continuous Glucose Monitoring and Clinical Pharmacist Collaboration to Improve Glycemic Control in Underserved Patients With Type 2 Diabetes
|
Powell, Jason |
|
|
46 |
1 |
p. e7-e11 |
artikel |
12 |
Potential Signals of COVID-19 as an Effect Modifier of Adverse Drug Reactions
|
Hauben, Manfred |
|
|
46 |
1 |
p. 20-29 |
artikel |
13 |
Predictors of a Good Diuretic Response and Administration Methods for Carperitide in Patients With Acute Heart Failure
|
Inamoto, Mayumi |
|
|
46 |
1 |
p. 12-19 |
artikel |
14 |
Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients
|
Alharbi, Abdulmajeed |
|
|
46 |
1 |
p. e1-e6 |
artikel |
15 |
Selexipag for the Treatment of Pediatric Pulmonary Hypertension: A Systematic Review
|
Li, Meng |
|
|
46 |
1 |
p. 59-68 |
artikel |
16 |
SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review
|
Maxson, Rebecca |
|
|
46 |
1 |
p. e23-e28 |
artikel |
17 |
Statin Use, Lipids, and 3-Hydroxy-3-Methyl-Glutaryl Coenzyme A Reductase Inhibition on Risk of Idiopathic Pulmonary Fibrosis
|
Zhao, Sizheng Steven |
|
|
46 |
1 |
p. 79-81 |
artikel |
18 |
Sulbactam/Durlobactam
|
Beninger, Paul |
|
|
46 |
1 |
p. 82-83 |
artikel |